Acute radiation pneumonitis after conformational radiotherapy for nonsmall cell lung cancer: Clinical, dosimetric, and associated-treatment risk factors | Zendy

Étienne Giroux-Leprieur | Zendy; D. Fernandez | Zendy; Gilles Châtellier | Zendy; Sylvain Klotz | Zendy; P. Giraud | Zendy; C. Durdux | Zendy

Open Access

Acute radiation pneumonitis after conformational radiotherapy for nonsmall cell lung cancer: Clinical, dosimetric, and associated-treatment risk factors

Author(s) -

Étienne Giroux-Leprieur,

D. Fernandez,

Gilles Châtellier,

Sylvain Klotz,

P. Giraud,

C. Durdux

Publication year - 2013

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.119339

Subject(s) - medicine , radiation therapy , gemcitabine , univariate analysis , lung cancer , pneumonitis , odds ratio , concomitant , induction chemotherapy , chemotherapy , oncology , confidence interval , complication , lung , gastroenterology , multivariate analysis

Conformational thoracic radiotherapy (CTR) is a key-treatment in locally advanced nonsmall cell lung cancer (LA-NSCLC). Acute radiation pneumonitis (ARP) is one of the major complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research